{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:06:03Z","timestamp":1769263563178,"version":"3.49.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":4567,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.micinf.2010.09.002","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T06:48:13Z","timestamp":1284360493000},"page":"613-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fighting mycobacterial infections by antibiotics, phytochemicals and vaccines"],"prefix":"10.1016","volume":"13","author":[{"given":"Denise","family":"Bamberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Jantzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Leidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Arend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2010.09.002_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00128071-200809040-00002","article-title":"Imported tropical infectious ulcers in travelers","volume":"9","author":"Zeegelaar","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.micinf.2010.09.002_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0733-8635(18)30129-3","article-title":"Atypical mycobacterial infections of the skin","volume":"12","author":"Hautmann","year":"1994","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.micinf.2010.09.002_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00063198-200205000-00003","article-title":"Infection and disease caused by environmental mycobacteria","volume":"8","author":"Zumla","year":"2002","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.micinf.2010.09.002_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3201\/eid0503.990307","article-title":"Emergence of a unique group of necrotizing mycobacterial diseases","volume":"5","author":"Dobos","year":"1999","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micinf.2010.09.002_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s15010-004-4001-4","article-title":"Nontuberculous mycobacterial infections: a clinical review","volume":"32","author":"Wagner","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.micinf.2010.09.002_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1473-3099(06)70464-9","article-title":"Mycobacterium ulcerans infection: control, diagnosis, and treatment","volume":"6","author":"Sizaire","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micinf.2010.09.002_bib7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1365-3156.2004.01339.x","article-title":"Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity","volume":"9","author":"Debacker","year":"2004","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micinf.2010.09.002_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1365-3156.2001.00746.x","article-title":"Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors","volume":"6","author":"Stienstra","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micinf.2010.09.002_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/path.1700600111","article-title":"A new mycobacterial infection in man","volume":"60","author":"Mac","year":"1948","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.micinf.2010.09.002_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clindermatol.2004.06.006","article-title":"Life-threatening mycobacteria infection","volume":"23","author":"Faber","year":"2005","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.micinf.2010.09.002_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(61)90793-0","article-title":"Mycobacterial skin ulcers in Uganda","volume":"2","author":"Clancey","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2010.09.002_bib12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.trstmh.2008.06.006","article-title":"Buruli ulcer (Mycobacterium ulcerans infection)","volume":"102","author":"Walsh","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2010.09.002_bib13","first-page":"145","article-title":"Buruli ulcer progress report, 2004\u20132008","volume":"83","year":"2008","journal-title":"WHO Wkly. Epidemiol."},{"key":"10.1016\/j.micinf.2010.09.002_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.envint.2006.01.002","article-title":"Pathways of Mycobacterium ulcerans infection: a review","volume":"32","author":"Duker","year":"2006","journal-title":"Environ. Int."},{"key":"10.1016\/j.micinf.2010.09.002_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archderm.1995.01690180121030","article-title":"Traditional treatment of Buruli ulcer in Benin","volume":"131","author":"Guedenom","year":"1995","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.micinf.2010.09.002_bib16","first-page":"785","article-title":"Mycobacterium ulcerans disease","volume":"83","author":"van der Werf","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.micinf.2010.09.002_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1099\/00222615-48-6-511","article-title":"Mycobacterium ulcerans \u2013 a mini-review","volume":"48","author":"Johnson","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micinf.2010.09.002_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrmicro2077","article-title":"Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans","volume":"7","author":"Demangel","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micinf.2010.09.002_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.20506\/rst.20.1.1270","article-title":"Mycobacterium ulcerans in wild animals","volume":"20","author":"Portaels","year":"2001","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.micinf.2010.09.002_bib20","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/AEM.68.9.4623-4628.2002","article-title":"Aquatic insects as a vector for Mycobacterium ulcerans","volume":"68","author":"Marsollier","year":"2002","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micinf.2010.09.002_bib21","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pntd.0000101","article-title":"Risk factors for buruli ulcer: a case control study in Cameroon","volume":"1","author":"Pouillot","year":"2007","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.micinf.2010.09.002_bib22","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(06)68807-7","article-title":"Buruli ulcer: emerging from obscurity","volume":"367","author":"Wansbrough-Jones","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2010.09.002_bib23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0140-6736(03)14417-0","article-title":"Mycolactones and Mycobacterium ulcerans disease","volume":"362","author":"van der Werf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2010.09.002_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/IAI.71.2.774-783.2003","article-title":"Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence","volume":"71","author":"Mve-Obiang","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2010.09.002_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/092986710789957814","article-title":"Neglected diseases caused by bacterial infections","volume":"17","author":"Bechtle","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.micinf.2010.09.002_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaad.2005.03.066","article-title":"Tropical dermatology: bacterial tropical diseases","volume":"54","author":"Lupi","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.micinf.2010.09.002_bib27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence","volume":"283","author":"George","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.micinf.2010.09.002_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/infdis\/157.3.577","article-title":"Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans","volume":"157","author":"Pimsler","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micinf.2010.09.002_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1473-3099(09)70234-8","article-title":"Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer","volume":"9","author":"Silva","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micinf.2010.09.002_bib30","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1371\/journal.pmed.0020108","article-title":"Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control","volume":"2","author":"Johnson","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.micinf.2010.09.002_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4269\/ajtmh.1998.59.1015","article-title":"Socioeconomic implications of Buruli ulcer in Ghana: a three-year review","volume":"59","author":"Asiedu","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2010.09.002_bib32","first-page":"144","article-title":"Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era","volume":"6","author":"Webb","year":"2009","journal-title":"East Afr. J. Public Health"},{"key":"10.1016\/j.micinf.2010.09.002_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clindermatol.2008.09.021","article-title":"Buruli ulcer","volume":"27","author":"Portaels","year":"2009","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.micinf.2010.09.002_bib34","series-title":"Buruli Ulcer: Diagnosis of Mycobacterium Ulcerans Disease","year":"2001"},{"key":"10.1016\/j.micinf.2010.09.002_bib35","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(99)01156-3","article-title":"Mycobacterium ulcerans infection","volume":"354","author":"van der Werf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2010.09.002_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1043659605285411","article-title":"The role of the African traditional healer in women\u2019s health","volume":"17","author":"Nelms","year":"2006","journal-title":"J. Transcult. Nurs."},{"key":"10.1016\/j.micinf.2010.09.002_bib37","unstructured":"Evil eye and stagnant waters, WHO Fact Sheet 193 (2000)."},{"key":"10.1016\/j.micinf.2010.09.002_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0035-9203(87)90206-9","article-title":"Infection and disease due to the environmental mycobacteria","volume":"81","author":"Grange","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2010.09.002_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0001-706X(95)00104-M","article-title":"Health education to promote community involvement in the control of tropical diseases","volume":"61","author":"Brieger","year":"1996","journal-title":"Acta Trop."},{"key":"10.1016\/j.micinf.2010.09.002_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1365-3156.2003.01089.x","article-title":"Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin","volume":"8","author":"Aujoulat","year":"2003","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micinf.2010.09.002_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-3156.2006.01795.x","article-title":"Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana","volume":"12","author":"Renzaho","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micinf.2010.09.002_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0035-9203(99)90104-9","article-title":"Mycobacterium ulcerans disease; Buruli ulcer","volume":"93","author":"Thangaraj","year":"1999","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2010.09.002_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00105-007-1447-1","volume":"59","author":"Streit","year":"2008","journal-title":"Hautarzt"},{"key":"10.1016\/j.micinf.2010.09.002_bib44","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.49.8.3182-3186.2005","article-title":"Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans","volume":"49","author":"Etuaful","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2010.09.002_bib45","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1371\/journal.pntd.0000321","article-title":"\u201cIt is me who endures but my family that suffers\u201d: social isolation as a consequence of the household cost burden of Buruli ulcer free of charge hospital treatment","volume":"2","author":"Grietens","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.micinf.2010.09.002_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5694\/j.1326-5377.2007.tb00800.x","article-title":"Outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australian case series","volume":"186","author":"O\u2019Brien","year":"2007","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.micinf.2010.09.002_bib47","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1128\/AAC.47.4.1228-1232.2003","article-title":"Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice","volume":"47","author":"Marsollier","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2010.09.002_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5694\/j.1326-5377.2007.tb00802.x","article-title":"Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia","volume":"186","author":"Johnson","year":"2007","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.micinf.2010.09.002_bib49","unstructured":"Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer), WHO."},{"key":"10.1016\/j.micinf.2010.09.002_bib50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jep.2008.08.022","article-title":"The potential of South African plants against Mycobacterium infections","volume":"119","author":"McGaw","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micinf.2010.09.002_bib51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jac\/dkf218","article-title":"In vitro activity of sitafloxacin (DU-6859a) alone, or in combination with rifampicin, against Mycobacterium ulcerans","volume":"50","author":"Dhople","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micinf.2010.09.002_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1179\/joc.2003.15.1.47","article-title":"Activities of sitafloxacin (DU-6859a), either singly or in combination with rifampin, against Mycobacterium ulcerans infection in mice","volume":"15","author":"Dhople","year":"2003","journal-title":"J. Chemother."},{"key":"10.1016\/j.micinf.2010.09.002_bib53","first-page":"333","volume":"79","author":"Nakanaga","year":"2004","journal-title":"Kekkaku"},{"key":"10.1016\/j.micinf.2010.09.002_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/47.1.93","article-title":"Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans","volume":"47","author":"Dhople","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micinf.2010.09.002_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.micinf.2010.09.002_bib56","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/AAC.00175-07","article-title":"Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease)","volume":"51","author":"Chauty","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2010.09.002_bib57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jep.2006.12.031","article-title":"Indian medicinal plants as a source of antimycobacterial agents","volume":"110","author":"Gautam","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micinf.2010.09.002_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-8741(01)00350-6","article-title":"The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis","volume":"79","author":"Newton","year":"2002","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micinf.2010.09.002_bib59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-2008-1074518","article-title":"Phytochemicals for bacterial resistance\u2013strengths, weaknesses and opportunities","volume":"74","author":"Gibbons","year":"2008","journal-title":"Planta Med."},{"key":"10.1016\/j.micinf.2010.09.002_bib60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.phytochem.2004.02.013","article-title":"Natural antimycobacterial metabolites: current status","volume":"65","author":"Okunade","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.micinf.2010.09.002_bib61","article-title":"Investigation of the medicinal plants found on the Palau Islands, their virtues and popular remedies","volume":"5","author":"Okabe","year":"1940","journal-title":"Bull. Trop. Indus. Palau, South Sea Islands, Japan"},{"key":"10.1016\/j.micinf.2010.09.002_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pharmthera.2007.03.016","article-title":"In search of cyclooxygenase inhibitors, anti-Mycobacterium tuberculosis and anti-malarial drugs from Thai flora and microbes","volume":"115","author":"Gale","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micinf.2010.09.002_bib63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/1099-1573(200008)14:5<303::AID-PTR712>3.0.CO;2-N","article-title":"A review of antimycobacterial natural products","volume":"14","author":"Newton","year":"2000","journal-title":"Phytother. Res."},{"key":"10.1016\/j.micinf.2010.09.002_bib64","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1055\/s-2001-18365","article-title":"Antimycobacterial plant terpenoids","volume":"67","author":"Cantrell","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/j.micinf.2010.09.002_bib65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.sajb.2005.09.009","article-title":"Antimycobacterial activity and possible mode of action of newly isolated neodiospyrin and other naphthoquinones from Euclea natalensis","volume":"72","author":"Kooy","year":"2006","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.micinf.2010.09.002_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ijantimicag.2003.11.008","article-title":"In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria","volume":"23","author":"Seidel","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micinf.2010.09.002_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-8741(96)01381-5","article-title":"Preliminary antimicrobial screening of four South African Asteraceae species","volume":"52","author":"Salie","year":"1996","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micinf.2010.09.002_bib68","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1586\/erv.09.87","article-title":"DNA vaccines against mycobacterial diseases","volume":"8","author":"Romano","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micinf.2010.09.002_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00430-009-0109-6","article-title":"Buruli ulcer disease: prospects for a vaccine","volume":"198","author":"Huygen","year":"2009","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib70","series-title":"Principles of Tuberculosis Management, Tuberculosis","first-page":"713","author":"Leibert","year":"2004"},{"key":"10.1016\/j.micinf.2010.09.002_bib71","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/QCO.0b013e328319bce6","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review","volume":"21","author":"Chan","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.micinf.2010.09.002_bib72","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1369-5274(99)80015-0","article-title":"T cell mediated immunity to Mycobacterium tuberculosis","volume":"2","author":"Stenger","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micinf.2010.09.002_bib74","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0952-7915(00)00116-3","article-title":"Immune responses in tuberculosis","volume":"12","author":"Flynn","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib76","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0952-7915(99)80055-7","article-title":"IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men","volume":"11","author":"Jouanguy","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib77","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1089\/jir.1997.17.583","article-title":"Infections in IFNGR-1-deficient children","volume":"17","author":"Jouanguy","year":"1997","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micinf.2010.09.002_bib78","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/14760584.2.4.561","article-title":"Prospects for vaccine development against Buruli disease","volume":"2","author":"Huygen","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micinf.2010.09.002_bib79","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/IAI.72.2.958-965.2004","article-title":"Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease","volume":"72","author":"Prevot","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2010.09.002_bib80","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.micinf.2010.09.002_bib81","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri1666","article-title":"Immune responses to tuberculosis in developing countries: implications for new vaccines","volume":"5","author":"Rook","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib82","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.micinf.2010.09.002_bib83","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2010.09.002_bib84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.micinf.2010.09.002_bib85","first-page":"194","article-title":"A bibliography of the complications of BCG vaccination. A comprehensive list of the world literature since the introduction of BCG up to July 1982, supplemented by over 100 personal communications","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv. Tuberc. Res."},{"key":"10.1016\/j.micinf.2010.09.002_bib86","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.micinf.2010.09.002_bib87","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.micinf.2010.09.002_bib88","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1462-5822.2005.00546.x","article-title":"Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin","volume":"7","author":"Coutanceau","year":"2005","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.micinf.2010.09.002_bib89","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.163.7.3928","article-title":"The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte\/T cell cytokine production and NF-kappa B function","volume":"163","author":"Pahlevan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib90","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1128\/IAI.00290-07","article-title":"Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection","volume":"75","author":"Torrado","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2010.09.002_bib91","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(76)90128-0","article-title":"The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda","volume":"70","author":"Smith","year":"1976","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2010.09.002_bib92","first-page":"111","article-title":"BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda","volume":"1","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2010.09.002_bib93","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0035-9203(93)90272-R","article-title":"Epidemiology of Buruli ulcer in Amansie West district, Ghana","volume":"87","author":"Amofah","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2010.09.002_bib94","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/IAI.69.9.5403-5411.2001","article-title":"Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2010.09.002_bib95","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1128\/iai.62.9.3679-3687.1994","article-title":"T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy","volume":"62","author":"Launois","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2010.09.002_bib96","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/IAI.70.4.2100-2107.2002","article-title":"Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice","volume":"70","author":"Moreira","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2010.09.002_bib97","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.micinf.2006.03.009","article-title":"Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer","volume":"8","author":"Coutanceau","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.micinf.2010.09.002_bib98","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1016\/j.vaccine.2005.08.035","article-title":"Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosis","volume":"24","author":"Romano","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2010.09.002_bib99","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.vaccine.2007.12.056","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3","volume":"26","author":"Gartner","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2010.09.002_bib100","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib101","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4049\/jimmunol.175.1.112","article-title":"Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help","volume":"175","author":"Kutzler","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2010.09.002_bib102","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/IAI.68.3.1706-1709.2000","article-title":"Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode","volume":"68","author":"Turner","year":"2000","journal-title":"Infect. Immun."}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457910002169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457910002169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:27:31Z","timestamp":1761143251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457910002169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":102,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1286457910002169"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2010.09.002","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fighting mycobacterial infections by antibiotics, phytochemicals and vaccines","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2010.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}